DR. PAUL J GRUBER M.D.
Prescription History 1134547656
Dermatology in Saint Peters, MO


Quality Rating: 83.31 out of 100 score

NPI Status: Active since April 01, 2014

Contact Information

5700 MEXICO RD STE 14
SAINT PETERS, MO
ZIP 63376
Phone: (636) 277-0371
Fax: (636) 447-4161

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PAUL J GRUBER M.D., an active Dermatology specialist practicing in Saint Peters, MO. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 303 documented patient claims. Among these therapy options, the most frequently utilized medication is Cephalexin, which accounts for 140 claims alone.


Cephalexin

Generic Formulation: CephalexinSpecialty: Dermatology
Provider Metrics Summary
Total Claims 140
30-Day Fills 140.0
Days Supply 920
MO State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills33.1
Peer Average Days Supply352
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 351.6% higher than the standard regional baseline profile for MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $689.45 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.92

State Avg Cost Per Claim

$9.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Diazepam

Generic Formulation: DiazepamSpecialty: Dermatology
Provider Metrics Summary
Total Claims 28
30-Day Fills 28.0
Days Supply 28
MO State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills42.1
Peer Average Days Supply1,054
Conservative Utilization

This provider writes prescriptions for this formulation 28.2% less frequently than the standard regional baseline metric for practitioners inside MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $23.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$0.85

State Avg Cost Per Claim

$7.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.

Therapeutic Applications

This medication is used to treat episodes of increased seizures (such as cluster or breakthrough seizures) in people who are already taking medications to control their seizures. This product is only recommended for short-term treatment of seizure attacks. It is not for ongoing daily use to prevent seizures. Uncontrolled seizures can turn into serious (possibly fatal) seizures that do not stop (status epilepticus). This medication is not recommended for children younger than 6 months of age because of the risk of serious side effects. Diazepam works by calming the brain and nerves. It belongs to a class of drugs known as benzodiazepines.

Doxycycline Hyclate

Generic Formulation: Doxycycline HyclateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 45
30-Day Fills 45.0
Days Supply 324
MO State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills35.2
Peer Average Days Supply491
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 40.6% more claims than the standard regional baseline profile for MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $428.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.52

State Avg Cost Per Claim

$24.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic tetracycline derivative with similar antimicrobial activity.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Doxycycline Monohydrate

Generic Formulation: Doxycycline MonohydrateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 46
30-Day Fills 46.0
Days Supply 346
MO State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills27.0
Peer Average Days Supply425
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 91.7% higher than the standard regional baseline profile for MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $585.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.72

State Avg Cost Per Claim

$25.60

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE.

Therapeutic Applications

This medication is used to treat a certain type of skin condition called rosacea. It helps to reduce the number of pimples and bumps on the face, but it may not decrease redness. It works by reducing skin inflammation caused by rosacea. Although doxycycline belongs to the class of antibiotics known as tetracyclines, this product does not work as an antibiotic because it does not stop the growth of bacteria. Do not use this product to treat any infection, including viral infections (such as the common cold, flu). Use this medication only as prescribed by your doctor.

Gentamicin Sulfate

Generic Formulation: Gentamicin SulfateSpecialty: Dermatology
Provider Metrics Summary
Total Claims 28
30-Day Fills 28.0
Days Supply 455
MO State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills29.3
Peer Average Days Supply461
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $748.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.72

State Avg Cost Per Claim

$50.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Therapeutic Applications

This medication is used to treat bacterial infections (such as blepharitis, conjunctivitis) of the eye and the skin around the eyes (such as eyelids). It is also used to prevent infection after eye injury or surgery. It belongs to a class of drugs known as aminoglycoside antibiotics. Gentamicin works by killing the bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. This drug should not be used in newborns due to an increased risk of serious side effects.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Dermatology
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 39
MO State Average Benchmarks
Peer Average Claims108.0
Peer Average 30-Day Fills108.4
Peer Average Days Supply2,082
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 85.2% less volume than the regional standard for practitioners inside MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $35.45 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.22

State Avg Cost Per Claim

$22.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. PAUL J GRUBER M.D. provides transparency into local medical care patterns within Saint Peters, MO.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Dermatology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.